Cytiva Launches Next-Generation Biacore 8 Series Systems to Accelerate Drug Discovery Workflows

New Biacore 8S and Biacore 8S+ systems combine rapid screening and high-quality molecular characterization in a single system Biacore Insight So...

May 22, 2026 | Friday | News
Myosin Therapeutics Doses First Patient in Phase 1/2 STAR-GBM Trial for Novel Glioblastoma Therapy MT-125

Myosin Therapeutics, a clinical stage biotechnology company developing innovative therapies for oncology, announced that the first patient has been dosed...

May 21, 2026 | Thursday | News
Rancho BioSciences Launches OmicsHQ™ to Accelerate Multi-Omics Research and AI-Driven Drug Discovery

OmicsHQ brings together comprehensive, expertly curated, standardized multi-omics datasets from across the scientific ecosystem, complete with pre-proces...

May 21, 2026 | Thursday | News
Thermo Fisher Scientific Opens Advanced Bioanalytical and Biomarker Laboratory in Sweden

The state-of-the-art facility enhances support for complex modalities across all phases of drug development Key facts Thermo Fisher opens new bioanal...

May 21, 2026 | Thursday | News
Lupin Receives U.S. FDA Tentative Approval for Generic Revefenacin Inhalation Solution

Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN)  announced that it has received...

May 20, 2026 | Wednesday | News
SERB Pharmaceuticals Acquires European and MENA Rights to Idefirix® from Hansa Biopharma in €115 Million Deal

SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) announced that they have entered into an ...

May 20, 2026 | Wednesday | News
Harbour BioMed Showcases Best-in-Class Potential of Hu-mAtrIx™-Engineered LET003 in Obesity Treatment

Hu-mAtrIx™-Enabled Next-Generation ACVR2A/2B-Targeting Antibody Demonstrates Potential to Become a Bes...

May 19, 2026 | Tuesday | News
Dr. Reddy’s Launches Canada’s First Generic Semaglutide Injection to Expand Access to Affordable GLP-1 Therapies Across G7 Markets

The launch follows Dr. Reddy’s receipt of the Notice of Compliance (NOC) from Health Canada on April 28th, 2026, marking the company’s re...

May 18, 2026 | Monday | News
Inside the Future of Biopharma Manufacturing: AES on Cleanroom Innovation, Contamination Control, and Operational Resilience

From advanced biologics and cell therapies to increasingly stringent regulatory expectations, today’s pharmaceutical manufacturing environments dem...

May 18, 2026 | Monday | Interaction
From Outsourcing to Strategic Alignment: The Future of CRO Partnerships in Biotech Building CRO Partnerships That Drive Speed, Continuity, and Clinical Success

As clinical development grows more complex and globally interconnected, biotech companies are under increasing pressure to build CRO partnerships that deli...

May 15, 2026 | Friday | Interaction
Andelyn Biosciences Launches LVV Curator® Platform to Accelerate Lentiviral Vector Manufacturing from Discovery to Clinic

New platform leverages the established Curator® platform methodology to industrialize Lentivirus processes from concept to clinic.   Andelyn Bio...

May 15, 2026 | Friday | News
Vetter Breaks Ground on Major Saarlouis Expansion to Accelerate Global Injectable Drug Manufacturing Capacity

Ceremonial groundbreaking kicks off the first construction phase Pharmaceutical service provider advances its expansion with a 50,000 sqm facility S...

May 15, 2026 | Friday | News
Profusa CEO Ben Hwang on Why Continuous Biochemical Monitoring Could Revolutionize Precision Medicine and Clinical Trials

  As healthcare shifts toward precision medicine and data-driven care, continuous biochemical monitoring is emerging as a transfo...

May 14, 2026 | Thursday | Expert Opinion
Gyre Therapeutics Achieves Key Regulatory Milestone as China Accepts NDA for F351 Liver Fibrosis Treatment

Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or the “Company”) (Nasdaq: GYRE), an innovative, commercial-stag...

May 14, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close